Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.09
BONE's Cash to Debt is ranked lower than
95% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. BONE: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
BONE' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.22 Max: No Debt
Current: 0.09
Equity to Asset -0.45
BONE's Equity to Asset is ranked lower than
95% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. BONE: -0.45 )
Ranked among companies with meaningful Equity to Asset only.
BONE' s 10-Year Equity to Asset Range
Min: -0.45  Med: 0.10 Max: 0.85
Current: -0.45
-0.45
0.85
F-Score: 4
Z-Score: -2.42
M-Score: -3.39
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -18.56
BONE's Operating margin (%) is ranked lower than
66% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. BONE: -18.56 )
Ranked among companies with meaningful Operating margin (%) only.
BONE' s 10-Year Operating margin (%) Range
Min: -55.87  Med: -21.39 Max: -3.49
Current: -18.56
-55.87
-3.49
Net-margin (%) -31.25
BONE's Net-margin (%) is ranked lower than
70% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. BONE: -31.25 )
Ranked among companies with meaningful Net-margin (%) only.
BONE' s 10-Year Net-margin (%) Range
Min: -126.27  Med: -29.74 Max: -3.49
Current: -31.25
-126.27
-3.49
ROA (%) -40.66
BONE's ROA (%) is ranked lower than
74% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. BONE: -40.66 )
Ranked among companies with meaningful ROA (%) only.
BONE' s 10-Year ROA (%) Range
Min: -148.33  Med: -38.52 Max: -15.44
Current: -40.66
-148.33
-15.44
ROC (Joel Greenblatt) (%) -52.60
BONE's ROC (Joel Greenblatt) (%) is ranked lower than
63% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.52 vs. BONE: -52.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
BONE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -314.89  Med: -48.75 Max: -26.82
Current: -52.6
-314.89
-26.82
Revenue Growth (3Y)(%) -8.50
BONE's Revenue Growth (3Y)(%) is ranked lower than
77% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. BONE: -8.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
BONE' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 3.30 Max: 40.7
Current: -8.5
0
40.7
EBITDA Growth (3Y)(%) 32.40
BONE's EBITDA Growth (3Y)(%) is ranked higher than
87% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. BONE: 32.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
BONE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -15.10 Max: 32.4
Current: 32.4
0
32.4
EPS Growth (3Y)(%) 31.70
BONE's EPS Growth (3Y)(%) is ranked higher than
82% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. BONE: 31.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
BONE' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -8.65 Max: 31.7
Current: 31.7
0
31.7
» BONE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

BONE Guru Trades in

BONE Guru Trades in

Q1 2015

BONE Guru Trades in Q1 2015

Jim Simons 16,100 sh (New)
» More
Q2 2015

BONE Guru Trades in Q2 2015

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with BONE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.68
BONE's P/S is ranked higher than
87% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. BONE: 0.68 )
Ranked among companies with meaningful P/S only.
BONE' s 10-Year P/S Range
Min: 0.42  Med: 1.29 Max: 20.1
Current: 0.68
0.42
20.1
Current Ratio 1.74
BONE's Current Ratio is ranked lower than
69% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. BONE: 1.74 )
Ranked among companies with meaningful Current Ratio only.
BONE' s 10-Year Current Ratio Range
Min: 0.74  Med: 1.98 Max: 6.87
Current: 1.74
0.74
6.87
Quick Ratio 0.84
BONE's Quick Ratio is ranked lower than
83% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. BONE: 0.84 )
Ranked among companies with meaningful Quick Ratio only.
BONE' s 10-Year Quick Ratio Range
Min: 0.29  Med: 0.91 Max: 4.93
Current: 0.84
0.29
4.93
Days Inventory 278.70
BONE's Days Inventory is ranked lower than
80% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 129.48 vs. BONE: 278.70 )
Ranked among companies with meaningful Days Inventory only.
BONE' s 10-Year Days Inventory Range
Min: 278.91  Med: 344.56 Max: 566.49
Current: 278.7
278.91
566.49
Days Sales Outstanding 55.09
BONE's Days Sales Outstanding is ranked higher than
72% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.92 vs. BONE: 55.09 )
Ranked among companies with meaningful Days Sales Outstanding only.
BONE' s 10-Year Days Sales Outstanding Range
Min: 45.73  Med: 78.25 Max: 85.75
Current: 55.09
45.73
85.75

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.53
BONE's Price/Median PS Value is ranked higher than
89% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. BONE: 0.53 )
Ranked among companies with meaningful Price/Median PS Value only.
BONE' s 10-Year Price/Median PS Value Range
Min: 0.38  Med: 1.05 Max: 14.35
Current: 0.53
0.38
14.35
Earnings Yield (Greenblatt) (%) -9.00
BONE's Earnings Yield (Greenblatt) (%) is ranked lower than
71% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. BONE: -9.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BONE' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -22.9  Med: 0.00 Max: 0
Current: -9
-22.9
0

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 51 74 115
EPS($) -1.43 -0.47 0.19
EPS without NRI($) -1.43 -0.47 0.19

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Bacterin International Holdings, Inc., develops, manufactures, and markets biologics products. The Company's products are used in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, and subcondral bone defect repair in knee and other joint surgeries. The Company's medical devices division develops coatings for medical devices and custom surgical instruments for use with allografts processed by its biologics division. Its medical devices division also works with its biologics division to produce and distribute OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. The Company's main competitors in the orthopedic biomaterials markets include: Medtronic, DePuy/Synthes, Arthrex, Smith & Nephew, Nuvasive, OrthoFix, Biomet, MTF, Stryker, RTI Surgical, AlloSource, Lifenet Health, Integra, ConMed/Linvatec, Wright Medical, Exactech, KCI, Baxter and Alphatec. It is registered with the FDA as a manufacturer of human cellular and tissue products (HCT/Ps) as well as medical devices.
» More Articles for BONE

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: GSVC, PSTB, BONE, ORIT May 09 2011 

More From Other Websites
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Sep 01 2015
Xtant Medical to Exhibit at EUROSPINE 2015 Sep 01 2015
Xtant Medical to Exhibit at EUROSPINE 2015 Sep 01 2015
XTANT MEDICAL HOLDINGS, INC. Financials Aug 27 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 27 2015
Xtant Medical to Present at the Rodman Renshaw 17th Annual Global Investment Conference Aug 27 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 25 2015
Xtant Medical Announces FDA Approval of OsteoSelect(R) PLUS Aug 25 2015
10-Q for Bacterin International Holdings, Inc. Aug 17 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 14 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report Aug 14 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 12 2015
Xtant Medical Reports First Half 2015 Financial Results Aug 12 2015
Xtant Medical Reports First Half 2015 Financial Results Aug 12 2015
Q2 2015 Xtant Medical Holdings Inc Earnings Release - After Market Close Aug 12 2015
The Zacks Analyst Blog Highlights: Bayer AG, Abbott Laboratories, Xtant Medical Holdings, RTI... Aug 11 2015
4 Hot Med-Instrument Stocks to Buy Aug 10 2015
XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 04 2015
Xtant Medical Holdings, Inc. to Report Second Quarter 2015 Financial Results on August 12, 2015 Aug 04 2015
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive... Aug 03 2015
Bacterin Closes Purchase of the Outstanding Common Stock of X-spine Systems, Inc. Jul 31 2015
Bacterin International Holdings Closes Offering of $65 Million of 6.00% Convertible Senior Notes Jul 31 2015
Bacterin International Holdings Closes Offering of $65 Million of 6.00% Convertible Senior Notes Jul 31 2015
Bacterin Closes Purchase of the Outstanding Common Stock of X-spine Systems, Inc. Jul 31 2015
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive... Jul 28 2015
Bacterin International Holdings Prices $65 Million of 6.00% Convertible Senior Notes Jul 27 2015
Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical Jul 27 2015
Bacterin Announces Preliminary Second Quarter Revenue Jul 09 2015
Bacterin International Holdings, Inc. Awarded Agreement With Premier, Inc. Jun 24 2015
Bacterin International Announces Signing of Agreement With Yankee Alliance Jun 19 2015
Bacterin Announces the Launch of ArthroFuse(TM) Jun 03 2015
CORRECTING AND REPLACING -- Bacterin Sets Annual Meeting and Record Dates May 15 2015
Bacterin Announces Record First Quarter 2015 Results May 05 2015
Bacterin Sets Annual Meeting and Record Dates May 04 2015
Bacterin to Report First Quarter 2015 Financial Results on May 5, 2015 Apr 23 2015
Bacterin Announces Preliminary First Quarter 2015 Results Apr 09 2015
OTC Markets Group Welcomes Bacterin International Holdings to OTCQX® Apr 09 2015
Bacterin International to Begin Trading on OTCQX Marketplace Apr 08 2015
Bacterin Announces OsteoSponge(R) Patent Apr 06 2015
Bacterin Announces Fourth Quarter and Year-End 2014 Results Mar 17 2015
Bacterin Announces Contract Extension With Novation Mar 16 2015
Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference Mar 11 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK